Mechanistic studies of the plant GCL demonstrated that reversible disulfide bond formation alters catalytic activity with the oxidized protein more active than the reduced protein (Jez et al., 2004)
Insurance approval may require documentation of BMI, obesity-related health conditions, previous treatment attempts, and medical necessity
Solution: Inform your healthcare provider about all medications or supplements youre taking
Tirzepatide starting at $199/month
A larger clinical trial randomly assigned more than 500 patients with type 2 diabetes and symptomatic peripheral neuropathy to one of the following treatments: (i) 600 mg/day of intravenous lipoic acid for three weeks followed by 1,800 mg/day of oral lipoic acid for six months, (ii) 600 mg/day of intravenous lipoic acid for three weeks followed by oral placebo for six months, or (iii) intravenous placebo for three weeks followed by oral placebo for six months (76)
We explain how each works, what the research supports, how they compare, and what anyone considering peptide therapy needs to understand before moving forward